Chk1 inhibitor LY2606368 showed a substantial decrease in cell viability in modified oral cell lines compared to the insensitive normal oral keratinocytes, which is similar to studies in which the effects of Chk1 inhibition in HNSCC were investigated [40]. Here, CHEK1 is linked to head and neck squamous cell carcinoma.